| Hepatoprotective role for ERMP1 in MASLD-driven hepatocarcinogenesis and β-catenin-mutated tumors | Cancer letters |  | | 2026 | 31 | 118 |
|
| S100A10-ANXA2 tetramer inhibition hampers hepatic stellate cell activation in human MASLD organoids | EMBO molecular medicine | | | 2026 | 10 | 21 |
|
| Comparative analysis of S100A10 and S100A11 in MASLD and hepatic cancer development revealed a tumor suppressive role for S100A10 | Cell death and disease | | | 2025 | 58 | 28 |
|
| ERMP1 as a newly identified ER stress gatekeeper in chronic kidney disease | American journal of physiology. Renal physiology | | | 2025 | 131 | 190 |
|
| Hepatic IR and IGF1R signaling govern distinct metabolic and carcinogenic processes upon PTEN deficiency in the liver | JHEP reports | | | 2025 | 145 | 344 |
|
| Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids | JHEP reports | | | 2024 | 102 | 148 |
|
| Endoplasmic reticulum stress in renal cell carcinoma | International journal of molecular sciences | | | 2023 | 175 | 371 |
|
| S100 proteins in fatty liver disease and hepatocellular carcinoma | International journal of molecular sciences | | | 2022 | 335 | 163 |
|
| MiR-22 deficiency fosters hepatocellular carcinoma development in fatty liver | Cells | | | 2022 | 279 | 322 |
|
